Yaliang Tong

Yaliang Tong

Auto-generated profile, based on publicly available information

Yaliang Tong

Department of Cardiology, China-Japan Union Hospital of Jilin University, Changchun, China

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in JACC: Cardiovascular Imaging
Verified
Journal Article
Closed access
JLJoo Myung Lee
Joo Myung Lee
GCGilwoo Choi
Gilwoo Choi
BKBon-Kwon Koo
Bon-Kwon Koo
DHDoyeon Hwang
Doyeon Hwang
JPJonghanne Park
Jonghanne Park
HKHyo-Soo Kim
Hyo-Soo Kim

1 April 2017 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
DHDoyeon Hwang
Doyeon Hwang
KJKi-Hyun Jeon
Ki-Hyun Jeon
JLJoo Myung Lee
Joo Myung Lee
JPJonghanne Park
Jonghanne Park
CKChee Hae Kim
Chee Hae Kim
BKBon-Kwon Koo
Bon-Kwon Koo

1 September 2016 in Circulation: Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
JLJoo Myung Lee
Joo Myung Lee
CKChee Hae Kim
Chee Hae Kim
BKBon-Kwon Koo
Bon-Kwon Koo
DHDoyeon Hwang
Doyeon Hwang
JPJonghanne Park
Jonghanne Park
HKHyo-Soo Kim
Hyo-Soo Kim
Background—: Recent evidence suggests that the diagnostic accuracy of myocardial perfusion imaging is improved by quantifying stress myocardial blood flow (MBF) in absolute terms. We evaluated a comprehensive quantitative 13 N-ammonia positron emission tomography ( 13 NH 3 -PET) diagnostic panel, including stress MBF, coronary flow reserve (CFR), and relative flow reserve (RFR) in conjunction with relative perfusion defect (PD) assessments to better detect functionally significant coronary artery stenosis. Methods and Results—: A total of 130 patients (307 vessels) with coronary artery disease underwent both 13 NH 3 -PET and invasive coronary angiography with fractional flow reserve (FFR) measurement. Diagnostic accuracy, optimal cut points, and discrimination indices of respective 13 NH 3 -PET quantitative measures were compared, with FFR as standard reference. The capacity to discern disease with stepwise addition of stress MBF, CFR, and RFR to qualitatively assessed relative PD was also gauged, using the category-free net reclassification index. All quantitative measures showed significant correlation with FFR (PET-derived CFR, r =0.388; stress MBF, r =0.496; and RFR, r =0.780; all P <0.001). Optimal respective cut points for FFR ≤0.8 and ≤0.75 were 1.99 and 1.84 mL/min per g for stress MBF and 2.12 and 2.00 for PET-derived CFR. Discrimination indices of quantitative measures that correlated with FFR ≤0.8 were all significantly higher than that of relative PD (area under the curve: 0.626, 0.730, 0.806, and 0.897 for relative PD, CFR, stress MBF, and RFR, respectively; overall comparison P <0.001). The capacity for functionally significant coronary stenosis was incrementally improved by the successive addition of CFR (net reclassification index=0.629), stress MBF (net reclassification index=0.950), and RFR (net reclassification index=1.253; all P <0.001) to relative PD. Conclusions—: Integrating quantitative 13 NH 3 -PET measures with qualitative myocardial perfusion assessment provides superior diagnostic accuracy and improves the capacity to detect functionally significant coronary artery stenosis. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifiers: NCT01621438 and NCT01366404.

1 November 2017 in Circulation: Cardiovascular Imaging
Verified
Journal Article
Closed access
JLJoo Myung Lee
Joo Myung Lee
JBJi-In Bang
Ji-In Bang
BKBon-Kwon Koo
Bon-Kwon Koo
DHDoyeon Hwang
Doyeon Hwang
JPJonghanne Park
Jonghanne Park
TATakashi Akasaka
Takashi Akasaka
Background—: 18 F-sodium fluoride ( 18 F-NaF) positron-emission tomography has been introduced as a potential noninvasive imaging tool to identify plaques with high-risk characteristics in patients with coronary artery disease. We sought to evaluate the clinical relevance of 18 F-NaF uptake using optical coherence tomography (OCT), intravascular ultrasound (IVUS), and coronary computed tomography angiography in patients with coronary artery disease. Methods and Results—: The target population consisted of 51 prospectively enrolled patients (93 stenoses) who underwent 18 F-NaF positron-emission tomography before invasive coronary angiography. 18 F-NaF uptake was compared with IVUS- and OCT-derived plaque characteristics. In the coronary computed tomography angiography subgroup (46 lesions), qualitative lesion characteristics were compared between 18 F-NaF–positive and 18 F-NaF–negative plaques using adverse plaque characteristics. The plaques with 18 F-NaF uptake showed significantly higher plaque burden, more frequent posterior attenuation and positive remodeling in IVUS, and significantly higher maximum lipid arc and more frequent microvessels in OCT (all P <0.05). There were no differences in minimum lumen area and area of calcium between 18 F-NaF–positive and 18 F-NaF–negative lesions. Among 51 lesions with 18 F-NaF–positive uptake, 48 lesions (94.1%) had at least one of high-risk characteristics. The 18 F-NaF tissue-to-background ratio in plaques with high-risk characteristics was significantly higher than in those without (1.09 [95% confidence interval, 0.85–1.34] versus 0.62 [95% confidence interval, 0.42–0.82], P <0.001 for IVUS definition; 0.76 [95% confidence interval, 0.54–0.98] versus 0.42 [95% confidence interval, 0.21–0.62], P =0.014 for OCT definition). Among the 15 lesions that met both IVUS- and OCT-defined criteria for high-risk plaque, 14 (93.3%) showed 18 F-NaF–positive uptake. There was no difference in the prevalence of plaques with any adverse plaque characteristics between 18 F-NaF–positive and 18 F-NaF–negative plaques in the coronary computed tomography angiography subgroup (85.2% versus 78.9%; P =0.583). Conclusions—: This study’s results suggest that 18 F-NaF positron-emission tomography can be a useful noninvasive diagnostic tool to identify and localize plaque with high-risk characteristics. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT02388412.

1 October 2017 in JACC
Verified
Journal Article
Closed access
JLJoo Myung Lee
Joo Myung Lee
JPJonghanne Park
Jonghanne Park
DHDoyeon Hwang
Doyeon Hwang
CKChee Hae Kim
Chee Hae Kim
KCKi Hong Choi
Ki Hong Choi
BKBon-Kwon Koo
Bon-Kwon Koo

1 June 2019 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
QTQianqian Tong
Qianqian Tong
CLCaizi Li
Caizi Li
WSWeixin Si
Weixin Si
XLXiangyun Liao
Xiangyun Liao
YTYaliang Tong
Yaliang Tong
PHPheng Ann Heng
Pheng Ann Heng